XRAY - NASDAQ

DENTSPLY SIRONA Inc.

XRAY·NASDAQ

$9.64

-3.8%

HealthcareMedical - Instruments & Supplies

DENTSPLY SIRONA Inc. manufactures and sells various dental products and technologies for professional dental market worldwide. The company operates through two segments, Technologies & Equipment, and Consumables. The Technologies & Equipment segment provides dental equipment, such as treatment centers, imaging equipment, motorized dental handpieces, and other instruments for dental practitioners and specialists; dental CAD/CAM technologies for dental offices to support various digital dental procedures, including dental restorations; dentist-directed clear aligner solutions, SureSmile, and direct-to-consumer clear aligner solutions, as well as high frequency vibration technology device; implants; and urology catheters and other healthcare-related consumable products. The Consumables segment offers endodontic products comprising drills, filers, sealers, irrigation needles, and other tools or single-use solutions, which support root canal procedures; restorative products that include artificial teeth, dental ceramics, digital dentures, precious metal dental alloys, and crown and bridge porcelain products. It also provides small equipment products, which comprise intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers, as well as dental anesthetics, prophylaxis paste, dental sealants, impression materials, teeth whiteners, and topical fluoride. The company was founded in 1877 and is headquartered in Charlotte, North Carolina.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$1.93B

EPS-3.0000

P/E Ratio-3.21

Earnings Date08/06/2026

5.43B

Assets

-6%

3Y-29.0%

5Y-42.0%

10Y-53.0%

4.09B

Total Liabilities

3Y+7.0%

5Y-7.0%

10Y+16.0%

1.34B

Total Equity

-31%

3Y-65.0%

5Y-73.0%

10Y-84.0%

DENTSPLY SIRONA Inc. Funding & Solvency Profile

XRAY · NASDAQ

Current Assets

Cash & Cash Equivalents326.00M

Net Receivables688.00M

Inventory642.00M

Other Current Assets367.00M

Total Current Assets2 B

Non-Current Assets

Property, Plant & Equipment1.00B

Goodwill & Intangible Assets2.12B

Long-Term Investments0.00

Other Non-Current Assets284.00M

Total Non-Current Assets1 B

Total Assets

5.43B

Financial Health Analysis

Current Ratio

1.51x

Strong liquidity. The company has adequate resources to meet short-term liabilities.

Debt-to-Equity Ratio

3.05x

High financial leverage. Heavy reliance on debt may indicate increased financial risk and potential solvency concerns.

Working Capital

680 M

Strong working capital position provides significant operational flexibility and financial cushion.

Asset Composition

37% Current

Capital-intensive business with significant long-term investments in property, equipment, or intangibles.

DENTSPLY SIRONA Inc. Balance Sheet

XRAY • NASDAQ

DENTSPLY SIRONA Inc. Balance Sheet	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013	Dec 2012	Dec 2011	Dec 2010	Dec 2009	Dec 2008	Dec 2007	Dec 2006
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	326M	272M	334M	365M	339M	438M	405M	309.6M	320.6M	383.9M	284.6M	151.6M	75M	80.1M	77.1M	540M	450.3M	204M	169.4M	65.1M
Short-Term Investments	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37K	258K	146.9M	79K
Cash & Short-Term Investments	326M	272M	334M	365M	339M	438M	405M	309.6M	320.6M	383.9M	284.6M	151.6M	75M	80.1M	77.1M	540M	450.4M	204.2M	316.3M	65.1M
Net Receivables	688M	606M	756M	685M	803M	706M	828M	701.9M	746.2M	636M	399.9M	426.6M	472.8M	442.4M	427.7M	344.8M	348.7M	319.3M	307.6M	290.8M
Accounts Receivables	688M	556M	695M	632M	750M	673M	782M	701.9M	746.2M	636M	399.9M	426.6M	472.8M	442.4M	427.7M	344.8M	348.7M	319.3M	307.6M	290.8M
Other Receivables	0.0	50M	61M	53M	53M	36M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Inventory	642M	564M	624M	627M	515M	476M	562M	598.9M	623.1M	517.1M	340.4M	387.1M	438.6M	402.9M	361.8M	308.7M	291.6M	306.1M	258M	232.4M
Prepaids	0.0	151M	113M	128M	111M	111M	121M	104.8M	100.3M	69.5M	24.1M	49.9M	36.1M	54.9M	32.9M	121.5M	127.1M	120.2M	100M	129.8M
Other Current Assets	367M	153M	146M	88M	84M	67M	84M	172.8M	120.7M	122.9M	132.9M	150.1M	121.4M	130.7M	113.4M	0.0	-37K	0.0	0.0	0.0
Total Current Assets	2B	1.7B	2B	1.9B	1.9B	1.8B	2B	1.9B	2B	1.9B	1.2B	1.2B	1.1B	1.1B	1B	1.3B	1.2B	949.9M	982M	718.2M
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)	1B	902M	978M	961M	971M	967M	961M	870.6M	876M	799.8M	558.8M	588.8M	637.2M	614.7M	591.4M	423.1M	439.6M	432.3M	371.4M	329.6M
Goodwill	1.1B	1.6B	2.4B	2.7B	4B	4B	3.4B	3.4B	4.5B	6B	2B	2.1B	2.3B	2.2B	2.2B	1.3B	1.3B	1.3B	1.1B	995.4M
Intangible Assets	974M	1.2B	1.7B	1.9B	2.3B	2.5B	2.2B	2.4B	2.8B	3B	600.7M	670.8M	795.3M	830.6M	791.1M	78.7M	89.1M	103.7M	76.2M	67.6M
Goodwill & Intangible Assets	2.1B	2.8B	4.1B	4.6B	6.3B	6.5B	5.6B	5.9B	7.3B	8.9B	2.6B	2.8B	3.1B	3B	3B	1.4B	1.4B	1.4B	1.2B	1.1B
Long-Term Investments	0.0	23M	0.0	0.0	0.0	0.0	0.0	-552.8M	-718M	-848.6M	-160.3M	-165.6M	-238.4M	-232.6M	-249.8M	-72.5M	-72.5M	-69M	-60.5M	-53.2M
Tax Assets	0.0	0.0	228M	0.0	0.0	0.0	0.0	552.8M	718M	848.6M	160.3M	165.6M	238.4M	232.6M	249.8M	72.5M	72.5M	69M	60.5M	53.2M
Other Non-Current Assets	284M	278M	48M	198M	121M	95M	69M	76.8M	156.2M	64.1M	59.1M	94.3M	220.2M	204.9M	169.9M	138M	28.8M	67.5M	118.6M	70.5M
Total Non-Current Assets	3.4B	4B	5.4B	5.8B	7.4B	7.6B	6.6B	6.8B	8.4B	9.8B	3.2B	3.4B	3.9B	3.9B	3.7B	1.9B	1.9B	1.9B	1.7B	1.5B
Total Assets	5.4B	5.8B	7.4B	7.6B	9.2B	9.4B	8.6B	8.7B	10.4B	11.7B	4.4B	4.7B	5.1B	5B	4.8B	3.3B	3.1B	2.8B	2.7B	2.2B
LIABILITIES
CURRENT LIABILITIES
Total Payables	330M	291M	305M	331M	325M	374M	375M	342M	338.6M	283.8M	153.8M	168.8M	147.2M	204.5M	158.2M	127.6M	113.2M	140.5M	121.8M	127.2M
Accounts Payable	300M	241M	305M	279M	262M	302M	308M	283.9M	284.4M	223M	133.6M	132.6M	132.8M	165.3M	149.1M	114.5M	100.8M	104.3M	82.3M	80M
Other Payables	30M	50M	0.0	52M	63M	72M	67M	58.1M	54.2M	60.8M	20.2M	72.4M	14.4M	39.2M	9.1M	13.1M	12.4M	36.2M	39.4M	47.3M
Accrued Expenses	171M	544M	193M	401M	424M	432M	417M	210.5M	223.6M	188.5M	141M	360.2M	136.8M	131.2M	119.4M	78.4M	249.2M	85.4M	189.4M	66.3M
Short Term Debt	360M	549M	322M	118M	182M	299M	2M	92.4M	30.1M	21.1M	12.1M	112.8M	309.9M	299M	276.7M	7.8M	82.2M	25.8M	1.2M	3M
Capital Lease Obligations (Current)	0.0	46M	56M	54M	50M	48M	44M	0.0	0.0	0.0	0.0	-220.3M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax Payables	30M	45M	49M	52M	63M	72M	67M	58.1M	61.5M	70.6M	25.1M	28.9M	14.4M	39.2M	9.1M	13.1M	12.4M	36.2M	39.4M	47.3M
Deferred Revenue	74M	95M	91M	84M	68M	53M	29M	29.3M	8.9M	14.1M	2.2M	3.5M	4.9M	5.5M	0.0	0.0	-110.5M	0.0	189.4M	181.2M
Other Current Liabilities	408M	64M	458M	182M	212M	166M	128M	339.1M	353.3M	260.1M	166.9M	8.3M	197.6M	287.6M	163.5M	146.3M	0.0	108.3M	0.0	114.9M
Total Current Liabilities	1.3B	1.6B	1.4B	1.2B	1.3B	1.4B	995M	1B	946.6M	771M	476M	653.6M	796.4M	927.8M	724.1M	360.1M	444.6M	360M	312.4M	311.4M
NON-CURRENT LIABILITIES
Long Term Debt	2B	1.6B	1.8B	1.8B	1.9B	2B	1.4B	1.6B	1.6B	1.5B	1.1B	1.2B	1.2B	1.2B	1.5B	604M	387.2M	423.7M	482.1M	367.2M
Deferred Revenue (Non-Current)	95M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-72.5M	0.0	0.0	0.0
Deferred Tax Liabilities (Non-Current)	86M	129M	0.0	287M	391M	381M	480M	552.8M	718M	848.6M	160.3M	165.6M	238.4M	232.6M	249.8M	72.5M	72.5M	69M	60.5M	53.2M
Other Non-Current Liabilities	457M	415M	730M	399M	528M	554M	480M	975.8M	1.2B	1.2B	446.5M	521.6M	537.5M	573M	657.2M	383.9M	349.3M	390M	364.7M	175.5M
Total Non-Current Liabilities	2.7B	2.2B	2.7B	2.7B	3B	3B	2.5B	2.5B	2.8B	2.8B	1.6B	1.7B	1.7B	1.8B	2.1B	987.9M	736.4M	882.7M	846.8M	595.9M
Capital Lease Obligations	93M	137M	181M	203M	199M	178M	164M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Liabilities	4.1B	3.8B	4.1B	3.8B	4.2B	4.4B	3.5B	3.6B	3.7B	3.5B	2.1B	2.3B	2.5B	2.7B	2.9B	1.3B	1.2B	1.2B	1.2B	907.3M
SHAREHOLDERS' EQUITY
Treasury Stock	-3.1B	-3.1B	-2.9B	-2.6B	-2.5B	-2.4B	-2.3B	-2.2B	-2B	-1.6B	-898.4M	-841.6M	-748.5M	-713.7M	-728M	-711.7M	-532M	-479.6M	-387.1M	-328.2M
Preferred Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Common Stock	3M	3M	3M	3M	3M	3M	3M	2.6M	2.6M	2.6M	1.6M	1.6M	1.6M	1.6M	1.6M	1.6M	1.6M	1.6M	1.6M	814K
Additional Paid-In Capital	6.6B	6.6B	6.6B	6.6B	6.6B	6.6B	6.6B	6.5B	6.5B	6.5B	237.8M	221.7M	255.3M	246.5M	229.7M	204.9M	195.5M	187.2M	173.1M	168.1M
Retained Earnings	-1.6B	-835M	205M	456M	1.5B	1.2B	1.4B	1.2B	2.3B	3.9B	3.6B	3.4B	3.1B	2.8B	2.5B	2.3B	2.1B	1.8B	1.6B	1.4B
Accumulated Other Comprehensive Income/Loss	-639M	-730M	-636M	-628M	-592M	-464M	-600M	-478.7M	-291M	-705.7M	-594M	-441.1M	-69.1M	-144.2M	-191M	24.2M	83.5M	39.6M	145.8M	79.9M
Other Total Stockholders' Equity	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-61K	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Stockholders' Equity	1.3B	1.9B	3.3B	3.8B	5B	4.9B	5.1B	5.1B	6.6B	8.1B	2.3B	2.3B	2.5B	2.2B	1.8B	1.8B	1.8B	1.6B	1.5B	1.3B
Total Equity	1.3B	1.9B	3.3B	3.8B	5B	4.9B	5.1B	5.1B	6.6B	8.1B	2.3B	2.3B	2.6B	2.2B	1.9B	1.9B	1.9B	1.6B	1.5B	1.3B
Minority Interest	1M	1M	1M	1M	1M	3M	2M	11.9M	11.6M	11.6M	1.4M	919K	42.9M	40.7M	36.1M	70.5M	74.9M	0.0	296K	222K
SUMMARY
Total Liabilities & Equity	5.4B	5.8B	7.4B	7.6B	9.2B	9.4B	8.6B	8.7B	10.4B	11.7B	4.4B	4.7B	5.1B	5B	4.8B	3.3B	3.1B	2.8B	2.7B	2.2B
Total Investments	0.0	23M	0.0	0.0	0.0	0.0	0.0	-552.8M	-718M	-848.6M	-160.3M	-165.6M	-238.4M	-232.6M	-249.8M	-72.5M	-72.5M	-68.8M	86.4M	-53.1M
Total Debt	2.5B	2.3B	2.3B	2.1B	2.3B	2.5B	1.6B	1.7B	1.6B	1.5B	1.1B	1.2B	1.2B	1.2B	1.5B	604M	387.2M	449.5M	483.3M	370.2M
Net Debt	2.1B	2B	2B	1.8B	2B	2B	1.2B	1.3B	1.3B	1.1B	856.4M	1B	1.1B	1.1B	1.4B	64M	-63.2M	245.5M	313.9M	305.1M
Shares Outstanding	199,551,969	199,551,969	199,551,969	199,551,969	199,551,969	199,551,969	199,551,969	199,551,969	199,551,969	199,551,969	199,551,969	199,551,969	199,551,969	199,551,969	199,551,969	199,551,969	199,551,969	199,551,969	199,551,969	199,551,969

SEC Filings

XRAY - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
10-Q 10-Q 2026 Q1 Q1	May 05, 2026	March 31, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 05, 2026	May 05, 2026	2026	View Filing
DEF 14A DEF 14A 2026 N/A	April 23, 2026	June 02, 2026	2026	View Filing
10-K 10-K 2025 FY FY	February 26, 2026	December 31, 2025	2025	View Filing
8-K 8-K 2026 N/A	February 26, 2026	February 26, 2026	2026	View Filing
8-K 8-K 2026 N/A	February 24, 2026	February 23, 2026	2026	View Filing
8-K 8-K 2026 N/A	January 14, 2026	January 14, 2026	2026	View Filing
8-K 8-K 2026 N/A	January 13, 2026	January 10, 2026	2026	View Filing
8-K 8-K 2025 N/A	December 31, 2025	December 24, 2025	2025	View Filing
8-K 8-K 2025 N/A	November 25, 2025	November 25, 2025	2025	View Filing

Showing 1 to 10 of 444 filings

Related Guides

Blog Categories

Continue your XRAY research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.